Keywords: Takeda, Envoy Thera, Bac-TRAP technology, CNS programs, M&A

Another acquisition for Takeda, Envoy Therapeutics for up to $140 million

Article | 07 November 2012

Print This

Takeda Pharmaceutical (TYO: 4502), Japan’s largest drugmaker, has clearly not quenched its thirst for acquisitions, as it announced yesterday ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in